The Role of Patient Expectations in Traumatic Orthopedic Outcomes-TEFTOM EURASIA

The Role of Patient Expectations in Traumatic Orthopedic Outcomes TEFTOM: The Trauma Expectation Factor - Trauma Outcomes Measure TEFTOM EURASIA

Design:

Prediction trial, up to 10 sites in Asia and Europe

Goal:

To better understand the "success" or "failure" after orthopedic trauma surgery by developing a model that can be applied clinically as a user-friendly "baseline" questionnaire - capable of predicting "success" or "failure" based on a patient's pre-surgical expectations of their final outcome and to validate a novel outcomes measure (TOM).

Primary aim:

To assess the psychometric properties of predictive validity, internal consistency and reproducibility of the trauma expectation factor (TEF) in the Eurasian population.

Secondary aim:

To assess the psychometric properties of criterion validity, internal consistency,reproducibility, and sensitivity to change of the TOM in the Eurasian population.

Key questions related to patient and surgeon expectations:

  • How different, or similar, are patient and surgeon expectations?
  • Do expectations change over time?
  • Do patient expectations predict outcomes in validated measures use today?

Study Overview

Study Type

Observational

Enrollment (Actual)

199

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, China
        • Queen Mary Hospital
      • Shanghai, China, 200233
        • Shanghai Sixth People's Hospital
      • Köln, Germany, 50931
        • Universitatsklinikum Koln
      • Bangalore, India, 560025
        • HOSMAT Hospital
      • Girona, Spain, 17007
        • Hospital Universitari de Girona Doctor Josep Trueta
      • Luzern, Switzerland, 6000
        • Kantonsspital Luzern
      • Zürich, Switzerland, 8063
        • Stadtspital Triemli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient 18 years of age or older with an isolated ankle or distal tibia fracture, scheduled for and undergoing one of the following surgeries for their fracture (Open fracture and internal fixation (ORIF, external fixation (EF) or EF followed by ORIF)

Description

Inclusion Criteria:

  • Isolated ankle or distal tibia fracture
  • Scheduled for and undergoing one of the following surgeries for their fracture:

    • Open fracture and internal fixation (ORIF)
    • external fixation (EF)
    • EF followed by ORIF
  • 18 years of age or older
  • Understand and read country national language at elementary level
  • Able to understand the purpose of the clinical trial,
  • Able and willing to conduct all follow-up visits
  • Signed informed consent

Exclusion Criteria:

  • Subject has previously undergone internal fixation surgery for this ankle/distal tibia fracture.
  • Subject has disease entity, or condition that precludes likelihood of bony union (e.g., metastatic cancer, metabolic bone disease).
  • Subject has severe dementia or other severe mental health problem that may preclude him/her from completing study questionnaires.
  • Subject is participating in other competing clinical research that may interfere with participation in this research.
  • Subject is unlikely to attend study related follow-up visits.
  • Subject has poly-trauma (more than one organ system compromised)
  • Subject has additional fracture(s) other than ankle fracture
  • Subject is a prisoner
  • Fracture occurred more than 28 days before surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
TEFTOM
Patient outcome measure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Teftom Questionnaire
Time Frame: one year
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Reto Babst, MD, Luzerner Kantonsspital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Actual)

February 1, 2014

Study Completion (Actual)

February 1, 2014

Study Registration Dates

First Submitted

May 28, 2010

First Submitted That Met QC Criteria

June 1, 2010

First Posted (Estimate)

June 2, 2010

Study Record Updates

Last Update Posted (Estimate)

June 19, 2014

Last Update Submitted That Met QC Criteria

June 18, 2014

Last Verified

June 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tibia Fracture (Isolated)

3
Subscribe